Israeli company liberDi received FDA 510(k) clearance for its Intelligent Dialysis Assistant, accompanying IDA cartridge with a medical supervision portal, and IDA smartphone app.
IDA allows patients to undergo peritoneal dialysis outside of a clinic while being remotely monitored by a medical professional via the device's telemedicine capabilities.
Peritoneal dialysis is one of the two methods...
CloudCath, the maker of a remote monitoring platform for catheter-based treatments, has closed a $12 million Series A financing round. Capital Integral headlined the raise, which also saw investments from FundRx, The Capital Partnership, Coconut Tree Investments, Stanford University’s StartX Fund and other unnamed strategic and individual investors.
WHAT THEY DO
CloudCath’s initial product is a...
As 2020 gets underway, the federal government has set its sights on bringing innovation to an area of health that affects one in seven Americans and costs the government more than NASA and the Department of Commerce combined, yet hasn’t seen major innovation since the 1970s.
That area is kidney disease. Both HHS Chief Technology Officer Ed Simcox and HHS Deputy Secretary Eric Hargan addressed the...
NTUC Income, a Singapore-based insurance cooperative and DaVita, a US-based company which provides kidney dialysis across the US and in 9 countries worldwide, recently announced a joint venture (JV), DaVita Singapore, to operate kidney dialysis centres in Singapore. The dialysis centres operated by the JV will serve as Income’s preferred healthcare facilities, akin to its panel of private...
The Department of Health and Human Services’ position of Chief Technology Officer is a relatively new one. President Barack Obama created the role in 2009 and appointed the first three people to hold the post: Todd Park, Bryan Sivak, and Susannah Fox.
That makes Bruce Greenstein the first ever HHS CTO appointed by a Republican president, or even by a non-Obama president. But unlike many Executive...
NxStage Medical, a medical technology outfit focused on advancing renal care, has received clearance from the FDA for its System One, which allows for solo home hemodialysis, without a care partner, during waking hours.
The company received its first clearance for home hemodialysis from the FDA in 2005, and in 2014 was cleared for home nocturnal hemodialysis. Since then, NxStage estimates that...
Outset Medical has raised $76.5 million in a series C round led by T. Rowe Price Associates. In addition to new investor T. Rowe Price Associates, existing investors Fidelity Management & Research Company, Partner Fund Management LP, Warburg Pincus, Perceptive Advisors and The Vertical Group also participated. This round of funding bring's the company's total funds raised to $185.5 million....
